DE3476666D1 - Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide - Google Patents

Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide

Info

Publication number
DE3476666D1
DE3476666D1 DE8484101001T DE3476666T DE3476666D1 DE 3476666 D1 DE3476666 D1 DE 3476666D1 DE 8484101001 T DE8484101001 T DE 8484101001T DE 3476666 T DE3476666 T DE 3476666T DE 3476666 D1 DE3476666 D1 DE 3476666D1
Authority
DE
Germany
Prior art keywords
peptide
leu
preparation
arg
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484101001T
Other languages
English (en)
Inventor
Shinro Tachibana
Shizuko Ohya
Yoshihiro Arakawa
Takahiro Nakazawa
Takeru Kaneko
Masuhiro Ikeda
Kiyomi Yamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3476666D1 publication Critical patent/DE3476666D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8484101001T 1983-02-01 1984-02-01 Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide Expired DE3476666D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58013785A JPS59141547A (ja) 1983-02-01 1983-02-01 鎮痛作用を有する新規ペプタイドおよび製法

Publications (1)

Publication Number Publication Date
DE3476666D1 true DE3476666D1 (en) 1989-03-16

Family

ID=11842901

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484101001T Expired DE3476666D1 (en) 1983-02-01 1984-02-01 Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide

Country Status (6)

Country Link
US (1) US4551273A (de)
EP (1) EP0115850B1 (de)
JP (1) JPS59141547A (de)
AT (1) ATE40698T1 (de)
CA (1) CA1248089A (de)
DE (1) DE3476666D1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
US5166916A (en) * 1988-12-14 1992-11-24 Asahi Kogaku Kogyo Kabushiki Kaisha Automatic gain control apparatus
CN1964970B (zh) 2004-04-07 2011-08-03 诺瓦提斯公司 Iap的抑制剂
PE20110218A1 (es) * 2006-08-02 2011-04-01 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
CN109021073B (zh) * 2018-08-30 2021-09-24 陕西师范大学 秦岭雨蛙镇痛肽ht2的改造体ht12及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
EP0004394B1 (de) * 1978-03-02 1981-04-15 Akzo N.V. Psychopharmakologische Peptide, Verfahren zu deren Herstellung und deren pharmazeutische Zusammensetzungen
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
JPS57118563A (en) * 1981-01-14 1982-07-23 Takeda Chem Ind Ltd Indole derivative and preparation of peptide
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs

Also Published As

Publication number Publication date
EP0115850A3 (en) 1987-02-04
US4551273A (en) 1985-11-05
EP0115850A2 (de) 1984-08-15
ATE40698T1 (de) 1989-02-15
EP0115850B1 (de) 1989-02-08
JPS59141547A (ja) 1984-08-14
CA1248089A (en) 1989-01-03

Similar Documents

Publication Publication Date Title
ES8203385A1 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
ES8708237A1 (es) Procedimiento para la preparacion de nuevos aldehidos pep- tidos
IE39528B1 (en) Pharmaceutically active peptides and method of use thereof
PT100234A (pt) Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao
CA2016627A1 (en) Proteinase inhibitors, process for the preparation thereof and medicaments containing these
IL108851A (en) Polypeptide bombesin antagonists, their preparation and pharmaceutical preparations containing them
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
ES8701228A1 (es) Un metodo para producir una propioxantina
EP0228192A3 (de) Renin-hemmende Oligopeptide, deren Herstellung und Anwendung
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
JPS55138391A (en) New synthetic method of peptide derivative
DE3476666D1 (en) Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide
ES8202787A1 (es) Un procedimiento para la preparacion de un hexapeptido ci- clico
EP0246795A3 (de) Synthetische natriuretische Peptide
MY103251A (en) Biologically active molecules
EP0652755A1 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin.
JPS57209270A (en) Proline derivative
ES8403482A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
IE790619L (en) Psychopharmacological peptides
EP0103858A3 (de) Peptiden, Verfahren zur Herstellung und deren pharmazeutische Zusammensetzungen
IE873144L (en) Substituted thienoimidazole-toluidine derivatives, a process¹for their preparation, pharmaceutical compositions¹containing them, and their use as inhibitors of gastric acid¹secretion
KR900701830A (ko) 신규의 펜타펩티드 및 그의 제조방법
DE3855751D1 (en) Hypoglycemische peptide
ATE91286T1 (de) Gefaessaktive peptide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee